{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:49:15Z","timestamp":1790250555111,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30371264"],"award-info":[{"award-number":["30371264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271843"],"award-info":[{"award-number":["81271843"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201297"],"award-info":[{"award-number":["81201297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Major Science and Technology Special Project for Infectious Diseases of China","award":["2012ZX10004503-012"],"award-info":[{"award-number":["2012ZX10004503-012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T14:06:03Z","timestamp":1473429963000},"page":"117-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in\u00a0vitro and in\u00a0vivo"],"prefix":"10.1016","volume":"134","author":[{"given":"Baosheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubiao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"D\u00f6rnbrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.007_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2016.08.007_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/open.201100003","article-title":"High cytotoxic activity of phosphonium salts and their complementary selectivity towards HeLa and K562 Cancer cells: identification of tri-n-butyl-n-hexadecylphosphonium bromide as a highly potent anti-HeLa phosphonium salt","volume":"1","author":"Bachowska","year":"2012","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.antiviral.2016.08.007_bib3","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1128\/JVI.64.11.5324-5332.1990","article-title":"The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation","volume":"64","author":"Bartenschlager","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","article-title":"Hepatitis B virus replication","volume":"13","author":"Beck","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mt.2013.285","article-title":"Recombinant AAV as a platform for translating the therapeutic potential of RNA interference","volume":"22","author":"Borel","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2016.08.007_bib6","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1128\/JVI.00101-11","article-title":"RNA elements directing translation of the duck hepatitis B Virus polymerase via ribosomal shunting","volume":"85","author":"Cao","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"e0145746","DOI":"10.1371\/journal.pone.0145746","article-title":"Stable human hepatoma cell lines for efficient regulated expression of nucleoside\/nucleotide analog resistant and vaccine escape hepatitis B virus variants and woolly monkey hepatitis B virus","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2012.11.039","article-title":"Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside\/nucleotide analogue therapy: finite treatment duration unlikely","volume":"58","author":"Chevaliez","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.coph.2010.06.007","article-title":"Viral vector-mediated RNA interference","volume":"10","author":"Couto","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3851\/IMP2713","article-title":"Inhibition of HBV replication in\u00a0vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes","volume":"19","author":"Crowther","year":"2014","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.08.007_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2014.03.002","article-title":"Mouse models of hepatitis B and delta virus infection","volume":"410","author":"Dandri","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.antiviral.2016.08.007_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.007_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/281646a0","article-title":"Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli","volume":"281","author":"Galibert","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.007_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2015.06.008","article-title":"Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities","volume":"121","author":"Gish","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2015.06.019","article-title":"Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent","volume":"121","author":"Gish","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.007_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.mt.6300116","article-title":"Combinatorial RNAi: a winning strategy for the race against evolving targets?","volume":"15","author":"Grimm","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2016.08.007_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/viro.2000.0432","article-title":"Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene","volume":"273","author":"G\u00fcnther","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.007_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/rmv.1762","article-title":"Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them","volume":"23","author":"Hareendran","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.1840220410","article-title":"Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an \u201cinhibition in solution\u201d assay","volume":"22","author":"Heijtink","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2016.08.007_bib20","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1128\/JVI.00605-15","article-title":"Hepatitis B virus-infected HepG2hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8+ T cells in\u00a0Vitro","volume":"89","author":"Hoh","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2016.08.007_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/hgtb.2013.016","article-title":"Lentiviral vector-mediated RNA silencing in the central nervous system","volume":"25","author":"Hutson","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.antiviral.2016.08.007_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021477","article-title":"Mouse models of hepatitis B virus pathogenesis","volume":"5","author":"Iannacone","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2016.08.007_bib24","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/v7092854","article-title":"Anti-HBV drugs: progress, unmet needs, and new hope","volume":"7","author":"Kang","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2016.08.007_bib25","doi-asserted-by":"crossref","first-page":"935295","DOI":"10.1155\/2013\/935295","article-title":"Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection","volume":"2013","author":"Kondo","year":"2013","journal-title":"ISRN Gastroenterol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib26","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/nar\/26.6.1536","article-title":"The distal elements, OCT and SPH, stimulate the formation of preinitiation complexes on a human U6 snRNA gene promoter in\u00a0vitro","volume":"26","author":"Kunkel","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.007_bib27","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.007_bib28","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.02832-15","article-title":"Hepatitis B virus infection of a mouse hepatic cell line reconstituted with human sodium taurocholate cotransporting polypeptide","volume":"90","author":"Lempp","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jb\/mvr086","article-title":"Core-APOBEC3C chimerical protein inhibits hepatitis B virus replication","volume":"150","author":"Li","year":"2011","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.antiviral.2016.08.007_bib30","first-page":"580","article-title":"Establishment of high level expression HBV transgenic BALB\/c mice and its genetic and expressive stability","volume":"23","author":"Liu","year":"2003","journal-title":"Chin. J. Vet. Sci."},{"key":"10.1016\/j.antiviral.2016.08.007_bib31","doi-asserted-by":"crossref","first-page":"e53392","DOI":"10.1371\/journal.pone.0053392","article-title":"Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.08.007_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2013.228","article-title":"Circumventing antivector immunity: potential use of nonhuman adenoviral vectors","volume":"25","author":"Lopez-Gordo","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.antiviral.2016.08.007_bib33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib34","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2217\/fmb.13.87","article-title":"Recent advances in developing nucleic acid-based HBV therapy","volume":"8","author":"Marimani","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virol.2007.10.039","article-title":"Co-replication analyses of naturally occurring defective hepatitis B virus variants with wild-type","volume":"372","author":"M\u00e4rschenz","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.007_bib36","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib37","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/nar\/29.12.2502","article-title":"An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene","volume":"29","author":"Myslinski","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.007_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0378-1119(88)90364-2","article-title":"Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization","volume":"66","author":"Nassal","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.antiviral.2016.08.007_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"Nassal","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.08.007_bib40","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2016.08.007_bib41","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2016.08.007_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/282575a0","article-title":"Hepatitis B virus genes and their expression in E. coli","volume":"282","author":"Pasek","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.007_bib43","doi-asserted-by":"crossref","first-page":"10818","DOI":"10.1073\/pnas.96.19.10818","article-title":"Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection","volume":"96","author":"Protzer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.007_bib44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.1207","article-title":"Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice","volume":"10","author":"Rauschhuber","year":"2008","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.antiviral.2016.08.007_bib45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/JVI.75.3.1104-1116.2001","article-title":"Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors","volume":"75","author":"Ren","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/JVI.02361-14","article-title":"Superinfection with woodchuck hepatitis virus strain WHVNY of livers chronically infected with strain WHV7","volume":"89","author":"Rodrigues","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/15665232113136660006","article-title":"Biosafety challenges for use of lentiviral vectors in gene therapy","volume":"13","author":"Rothe","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.antiviral.2016.08.007_bib48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jmv.1890330407","article-title":"Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen","volume":"33","author":"S\u00e4llberg","year":"1991","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib49","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0161-5890(91)90114-Y","article-title":"Human and murine B-cells recognize the HBeAg\/beta (or HBe2) epitope as a linear determinant","volume":"28","author":"S\u00e4llberg","year":"1991","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11684-014-0335-1","article-title":"Current hepatitis B treatment guidelines and future research directions","volume":"8","author":"Skupsky","year":"2014","journal-title":"Front. Med."},{"key":"10.1016\/j.antiviral.2016.08.007_bib51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2006.05.019","article-title":"Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus","volume":"45","author":"Sun","year":"2006","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jhep.2009.10.038","article-title":"Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites","volume":"52","author":"Sun","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib53","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.08.007_bib54","doi-asserted-by":"crossref","first-page":"e60306","DOI":"10.1371\/journal.pone.0060306","article-title":"Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.08.007_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2015.06.004","article-title":"Determinants of hepatitis B and delta virus host tropism","volume":"13","author":"Winer","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.08.007_bib56","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2016.08.007_bib57","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.70.7.4646-4654.1996","article-title":"A\u00a0\u201chumanized\u201d green fluorescent protein cDNA adapted for high-level expression in mammalian cells","volume":"70","author":"Zolotukhin","year":"1996","journal-title":"J.\u00a0Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216301255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:30:35Z","timestamp":1601058635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216301255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":57,"alternative-id":["S0166354216301255"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in\u00a0vitro and in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}